Bruker Corporation (BRKR)

Cash ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Cash and cash equivalents	US$ in thousands	183,400	148,100	169,700	340,100	488,300	363,600	574,800	597,900	645,500	626,200	723,000	816,100	1,068,200	573,000	608,100	696,800	681,800	567,100	746,800	795,500
Short-term investments	US$ in thousands	—	—	12,700	12,800	12,000	19,300	16,900	15,500	0	0	0	100,000	100,000	96,800	97,900	50,000	50,000	50,000	50,000	56,200
Total current liabilities	US$ in thousands	1,281,300	1,322,100	1,304,500	1,182,500	1,202,100	1,072,300	1,050,900	1,048,500	914,300	864,600	818,400	880,500	938,500	921,200	954,600	943,500	791,900	683,200	749,700	765,800
Cash ratio		0.14	0.11	0.14	0.30	0.42	0.36	0.56	0.59	0.71	0.72	0.88	1.04	1.24	0.73	0.74	0.79	0.92	0.90	1.06	1.11

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($183,400K + $—K) ÷ $1,281,300K
= 0.14

The cash ratio of Bruker Corporation has shown a gradual decline over the past few years, indicating a decreasing ability to cover its short-term liabilities solely with cash and cash equivalents. The ratio stood at 1.11 as of March 31, 2020, but has since dropped to 0.14 as of June 30, 2024. This downward trend raises concerns about the company's liquidity position and its ability to meet its immediate financial obligations using available cash resources. It is essential for Bruker Corporation to closely monitor and manage its cash levels to ensure it maintains a healthy cash position for operational needs and to weather potential financial uncertainties.